We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Information for manufacturers and users of medical devices containing plastic with DEHP phthalates.
Sets out the payment due from members of the voluntary scheme for branded medicines pricing and access in 2022.
Provide innovators and developers of innovative products access to MHRA scientific expertise, regulatory guidance and an enhanced advice and signposting service.
Information on the measures in the Health Service Medical Supplies (Costs) Bill.
Information for patients who have been prescribed Lagevrio (molnupiravir), the COVID-19 oral antiviral medication.
From discovery to real-world impact, VDEC equips scientists with the expertise and facilities to navigate each step in the development of vaccines and therapeutics.
VDEC works with global leaders from all sectors to develop and deliver the vaccine and therapeutic products we need to protect us from infectious diseases.
The pre-clinical evaluation team at VDEC provides a safe and controlled environment to test new vaccines and therapeutics before they progress to clinical trials
Sets out the process for pharmaceutical companies to appeal against decisions made by the Secretary of State for Health and Social Care.
Guidance and specifications for the recording and extraction of CTAD data from laboratories in England processing LA and NHS commissioned chlamydia tests.
Guidance for healthcare professionals on providing free prescriptions for participants in the HEAL-COVID or STIMULATE-ICP long COVID clinical trials.
Advice against the use of homeopathic remedies for the prevention or treatment of malaria.
This external quality assessment (EQA) scheme is suitable for laboratories that routinely test for a range of food-borne pathogens and indicator organisms.
Device-specific guidance for manufacturers on reporting adverse incidents under the vigilance system
Guidance for manufacturers on the regulations that apply to prosthetic, orthotic and ophthalmic devices.
Guidance for health professionals on dealing with Listeriosis in relation to Sainsbury’s national recall of products on 26 June 2017.
What you need to do to supply investigational medicinal products (IMPs) from Great Britain to Northern Ireland.
Guidance to help medicine manufacturers meet safe limits on levels of nitrosamine impurities in medicines.
This is a work sharing model for the co-ordinated assessment of a generic application that has been filed with multiple Access Consortium agencies.
How the ‘Written Confirmation’ process operates for active substances manufactured in Great Britain (England, Wales and Scotland).
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).